GlaxoSmith (GLAXO) Stock Price and Company Financials
Rs. 316.42
Rs. 1.42 (0.45%)
Last updated: 2026-09-28
Annual Financials (Latest Year: 2025)
SalesRs. 65,900,901,000
Total revenue generated from core business operations during the year.
Profit After TaxRs. 10,025,315,000
Net earnings after all expenses, interest, and taxes – the "bottom line".
Earnings Per Share (EPS)Rs. 31.48
Profit allocated to each share – higher EPS means better profitability per share.
Gross Profit Margin37.00%
Percentage of revenue left after deducting cost of goods sold – shows production efficiency.
Net Profit Margin15.21%
What percentage of revenue becomes actual profit after all expenses – a key profitability measure.
EPS Growth53.41%
Year‑over‑year increase in earnings per share – indicates growing profitability.
Business Description:
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
GlaxoSmithKline Pakistan Limited is incorporated in Pakistan as a limited liability company. It is engaged in manufacturing and marketing of research based ethical specialties and pharmaceutical products. The Company is a subsidiary of S.R. One International B.V., incorporated in Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc).
*Annual figures from latest financial statement
| Open | Close | Low | High | Volume |
|---|---|---|---|---|
| 315.00 | 316.42 | 314.00 | 317.49 | 65,260 |